PolyPid (FRA:2PV) General and Admin. Expense: €6.54 Mil (TTM As of Mar. 2026)

PolyPid FRA:2PV -9.43% 14 General and Admin. Expense is €6.54 Mil as of Mar. 2026. GuruFocus rates FRA:2PV with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. PolyPid's General and Admin. Expense for the three months ended in Mar. 2026 was €1.38 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €6.54 Mil.

PolyPid General and Admin. Expense Related Terms

PolyPid General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for PolyPid's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PolyPid General and Admin. Expense Chart

PolyPid Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

General and Admin. Expense

Get a 7-Day Free Trial

8.50

7.56

5.07

4.08

6.13

PolyPid Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
General and Admin. Expense	Get a 7-Day Free Trial															1.09	2.16	1.51	1.50	1.38

14GF Score

PolyPid Ltd FRA:2PV

General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

PolyPid General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.54 Mil.

Frequently Asked Questions Learn more about General and Admin. Expense →

What does a General and Admin. Expense of €6.54 Mil mean?

PolyPid (FRA:2PV) has a General and Admin. Expense of €6.54 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on PolyPid and its competitors.

Is PolyPid's General and Admin. Expense too high?

PolyPid's current General and Admin. Expense is €6.54 Mil. Overall, PolyPid has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.

How does PolyPid's General and Admin. Expense compare to LONA and ANIX?

PolyPid's General and Admin. Expense of €6.54 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good General and Admin. Expense for a Biotechnology company?

A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high General and Admin. Expense mean?

A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on PolyPid and its competitors. PolyPid's current General and Admin. Expense is €6.54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is PolyPid stock overvalued right now?

PolyPid (FRA:2PV) has a current General and Admin. Expense of €6.54 Mil. The current General and Admin. Expense is €6.54 Mil. PolyPid's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is General and Admin. Expense calculated?

General and Admin. Expense is calculated from a company's financial statements. For PolyPid (FRA:2PV), the current General and Admin. Expense is €6.54 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PolyPid Business Description

Industry Healthcare Biotechnology

Comparable Companies LONA ANIX SGMO OKYO ICCC AARD NRXS TELO PTHS CUE VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges PYPD:USA

Address 18 Hasivim Street, Petach Tikva, ISR, 495376

Website https://www.polypid.com

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

14GF Score

Get the complete analysis for FRA:2PV

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.99

Price

View FRA:2PV Analysis

See General and Admin. Expense data for all stocks →